Ruxience 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB23FEVX8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,017
Award facts
- Contract value 100% obligated
- $20,016.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,016.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561863944 Ruxience 500 MG/50 ML VIAL 50ML. The contract has a period of performance from August 18, 2023 through August 21, 2023. Ruxience is a biosimilar product to Rituxan and will be delivered to the prime contractor's facility in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information.
Quick answers
Who was awarded contract SPE2DB23FEVX8?
SPE2DB23FEVX8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2023.
How much is contract SPE2DB23FEVX8 worth?
The government has obligated $20,017 on SPE2DB23FEVX8.
Is contract SPE2DB23FEVX8 an order under another contract?
Yes. SPE2DB23FEVX8 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB23FEVX8 competed?
The extent of competition for SPE2DB23FEVX8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award